Showing results (41-50 of 208) with videos related to

Sort By:
Pageof 21
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patientsThéodore Girinsky, Anne Aupérin, Vincent Ribrag, et al.
Blood Advances|June 20, 2020
KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failurePhilippe Armand, John Kuruvilla, Jean-Marie Michot, et al.
Leukemia & Lymphoma|June 7, 2012
Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphomaBénédicte Deau, Emmanuel Bachy, Vincent Ribrag, et al.
Investigational New Drugs|January 21, 2015
Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemiaFranck Morschhauser, Louis Terriou, Bertrand Coiffier, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2011
Tumour growth rates and RECIST criteria in early drug developmentCarlos Gomez-Roca, Serge Koscielny, Vincent Ribrag, et al.
Blood|October 15, 2005
NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndromeThorsten Braun, Gabrielle Carvalho, Arnaud Coquelle, et al.
Cancer Chemotherapy and Pharmacology|September 23, 2015
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)Benoit You, Gilles Salles, Emmanuel Bachy, et al.
Carcinogenesis|October 27, 2006
Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 geneSophie Queille, Lionel Luron, Alain Spatz, et al.
Gene|January 18, 2016
Histone deacetylase inhibitor abexinostat affects chromatin organization and gene transcription in normal B cells and in mantle cell lymphomaDiana Markozashvili, Andrei Pichugin, Ana Barat, et al.
Blood|May 12, 2017
Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphomaPier Luigi Zinzani, Vincent Ribrag, Craig H Moskowitz, et al.
Pageof 21